14.83
4.08%
-0.63
Handel nachbörslich:
15.15
0.32
+2.16%
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
1.00
|
- | - | - | - |
Operating Expenses
|
40.79%
6.627
|
4.707 | 5.368 | 8.00 | 7.427 |
Benefits Costs and Expenses |
6.919
|
- | - | - | - |
Costs And Expenses |
6.919
|
- | - | - | - |
Operating Income/Loss |
19.55%
-5.627
|
-4.707 | -5.368 | -8.00 | -7.427 |
Income/Loss From Continuing Operations Before Tax |
33.28%
-5.919
|
-4.441 | -8.54 | -7.211 | -5.774 |
Income Tax Expense/Benefit |
0.10
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
35.53%
-6.019
|
-4.441 | -8.54 | -7.211 | -5.774 |
Net Income/Loss
|
35.53%
-6.019
|
-4.441 | -8.54 | -7.211 | -5.774 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
19.83%
-1.154
|
-0.963 | -1.886 | -1.592 | -1.275 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):